Solana Company (HSDT) Research

Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.

Market snapshot

Symbol
HSDT
Price
$1.62
Day change
+1.25%
Market cap
$94.6M
P/E ratio
-0.91x
52-week range
1.185-25.5
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months

Peer companies

  • Perspective Therapeutics, Inc. (CATX)
  • Electromed, Inc. (ELMD)
  • InfuSystem Holdings, Inc. (INFU)
  • Inogen, Inc. (INGN)
  • Nano-X Imaging Ltd. (NNOX)
  • Outset Medical, Inc. (OM)
  • Profound Medical Corp. (PROF)
  • Quanterix Corporation (QTRX)

Recent insider activity

  • Jiang Cosmo Yi — M-Exempt (1005040 shares) on 2026-06-02
  • Jiang Cosmo Yi — M-Exempt (1005040 shares) on 2026-06-02
  • Jiang Cosmo Yi — F-InKind (610 shares) on 2026-06-02
  • Jiang Cosmo Yi — A-Award (1005040 shares) on 2025-09-18
  • Mello Sergio — A-Award (18564 shares) on 2026-05-21

Open Solana Company (HSDT) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.